Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Medicines Law & Policy
6 POSTS
0 COMMENTS
Medicines Law & Policy welcomes WHO’s Solidarity Call to Action to realise equitable global...
Medicines Law & Policy
-
May 29, 2020
Watch the webinar on the WHO Covid-19 Technology Pool
Medicines Law & Policy
-
May 15, 2020
Drug Price Transparency Calls Move from South Africa to World Health Assembly
Medicines Law & Policy
-
May 18, 2019
WHO Fair Pricing Forum: Watching for Drug Industry Accountability
Medicines Law & Policy
-
April 11, 2019
Medicines Law & Policy expert wins Prescrire Prize for “major reference work” on IP...
Medicines Law & Policy
-
October 5, 2017
“The diseases were in the South and the drugs were in the North”: Ellen...
Medicines Law & Policy
-
July 7, 2017
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
This work is licensed under Creative Commons.